Related Experiment Video
Updated: May 10, 2026

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
Published on: May 12, 2020
Phage Therapy for Acinetobacter baumannii Infections: A Review on Advances in Classification, Applications, and
Yilin Wang1, Liuyan Li1, Yuqi Liang2
1The Second Clinical School of Medicine, Anhui Medical University, Hefei 230032, China.
Phage therapy shows promise against carbapenem-resistant Acinetobacter baumannii (CRAB). Innovations like phage cocktails, antibiotic synergy, and genetic engineering enhance efficacy, offering new strategies for CRAB infections.
Area of Science:
- Bacteriophage research
- Microbial genomics
- Precision antibacterial strategies
Background:
- Carbapenem-resistant Acinetobacter baumannii (CRAB) presents a significant global health challenge.
- Phage-based therapies are emerging as a potential precision antibacterial strategy.
- Traditional phage classification is being updated by modern whole-genome phylogeny.
Purpose of the Study:
- To systematically review recent advancements in Acinetobacter baumannii phage therapy.
- To explore strategies for overcoming limitations of natural phage therapy.
- To identify challenges and future directions for phage therapy against CRAB.
Main Methods:
- Systematic review of recent literature on Acinetobacter baumannii phages.
- Analysis of modern phage taxonomy based on whole-genome phylogeny.
- Evaluation of enhanced phage therapy approaches including cocktails, antibiotic synergism, and genetic engineering.
Main Results:
- Modern taxonomy reclassifies A. baumannii phages into Caudoviricetes, correlating clades with host tropism.
- Phage cocktails and phage-antibiotic synergism significantly improve antibacterial efficacy against CRAB.
- Preclinical models show efficacy in pneumonia, wound healing, and immunomodulation.
- Optimized delivery methods (nebulization, hydrogels) and genetic engineering show potential.
Conclusions:
- Phage therapy, enhanced by cocktails, synergism, and engineering, offers innovative solutions for CRAB infections.
- Further validation of genetic stability and development of clinical translation standards are crucial.
- Integrating metagenomics and synthetic biology is key for precision medicine frameworks against CRAB.
More Related Videos
08:37The Application of Open Searching-based Approaches for the Identification of Acinetobacter baumannii O-linked Glycopeptides
Published on: November 2, 2021
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Related Concept Videos
Lytic Cycle of Bacteriophages
Acute Pyelonephritis II: Diagnostic Studies and Management
Microorganisms in Medicine and Therapeutics
Gene Regulation in Microbial Communities: Quorum Sensing
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance